• AML
  • Qui Tam
  • SEC
  • CFTC
  • FCPA
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
The Truth at Any Cost.
Qui Tam, Compliance and Anti-Corruption News.
Whistleblower Network News
No Result
View All Result
Home False Claims-Qui Tam

Generic Pharmaceutical Companies To Pay $447.2 Million To Resolve Allegations Of FCA Violations And Price-Fixing

Peter BriccettibyPeter Briccetti
October 6, 2021
in False Claims-Qui Tam
Reading Time: 3 mins read
FCA
Share on TwitterShare on FacebookShare on LinkedInEmail

Generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, will pay $447.2 million to settle allegations that they conspired to artificially inflate the price of multiple generic drugs. According to a U.S. Department of Justice (DOJ) press release, this conspiracy allegedly resulted in higher than normal drug prices for federal medical programs and their beneficiaries.

The government alleged that by communicating with each other and agreeing on generic drug prices, these three companies both paid and received illicit compensation through cooperation. Under the Anti-Kickback Statute of the False Claims Act, this kind of cooperation can be considered a kickback. According to the press release, this kickback scheme allegedly took place between 2013 and 2015.

The agreed upon settlements for this case demonstrate the seriousness of the alleged False Claims Act violations, with Taro Pharmaceuticals agreeing to pay $213.2 million, Sandoz paying $185 million, and Apotex on the line for $49 million. The drugs implicated in the alleged kickback scheme range from hypertension and cholesterol treatment drugs to arthritis treatment medications, and even include antifungal and skin treatment creams.

Register for National Whistleblower Day

Artificially inflating the prices of generic drugs through conspiracy jeopardizes the ability of individuals to continue to use medication that makes their lives safer and more comfortable. Raising drug prices to artificially high levels also erodes trust in the pharmaceutical and greater American medical system, damaging reputations and relationships between the public and medical professionals. Inflating prices through collusion damages Medicare and other federal medical programs by tricking the government into paying more for necessary medical services and wasting taxpayer dollars.

“Conspiring to raise prices on generic medications is illegal and could prevent patients from being able to afford their needed prescription drugs. Americans have the right to purchase generic drugs set by fair and open competition, not collusion,” said Special Agent in Charge Maureen R. Dixon of the Philadelphia Regional Office of the Inspector General, Department of Health and Human Services (HHS-OIG). “HHS-OIG along with our law enforcement partners will continue to investigate allegations of companies engaging in actions that put the public and the Medicare program at risk.”

Another aspect of the settlement requires all three companies to enter five-year Corporate Integrity Agreements (CIAs). These agreements are designed to increase oversight over future high level corporate decisions and develop systems for increased transparency within each organization. All three companies will also have to implement “compliance measures including risk assessment programs, executive recoupment provisions and compliance-related certifications from company executives and board members.”

While a whistleblower was not mentioned in the settlement, this action shows the strength and relevancy of the False Claims Act, even when a whistleblower is not involved. The False Claims Act and it’s essential medical elements like the Stark Act and Anti-Kickback provisions are the backbone of the U.S.’s defense against medical fraud.

Whistleblowers often make large disclosures in cases like this one, and reap large percentages of the settlements as a reward for doing so. In a qui tam action against a company violating the False Claims Act and defrauding the government, whistleblowers are entitled to 15 to 30% of the total recovered amount.

Read the DOJ’s press release here.

Read more False Claims Act/qui tam news on WNN.

Tags: False Claims Act
Previous Post

South African Whistleblower Advocate John Clarke: WNN Exclusive Interview

Next Post

MSPB a Step Closer to Quorum Following Senate Committee Vote

Peter Briccetti

Peter Briccetti

Peter Briccetti is a contributing editor with Whistleblower Network News. He writes about breaking whistleblower news, and False Claims Act whistleblowers, FCPA whistleblowers, and tax fraud whistleblowers. Peter is a graduate of Hamilton College with a degree in History and an interest in politics and anti-corruption law. At Hamilton, he wrote for the Hamilton College Spectator as an editor and contributor.

Next Post
IRS Commissioner

MSPB a Step Closer to Quorum Following Senate Committee Vote

Receive Daily Alerts

Subscribe to receive daily breaking news and legislative developments sent to your inbox.

  • This field is for validation purposes and should be left unchanged.

Most Popular

Advocates Detail Need for SEC Whistleblower Reform

Raytheon Whistleblower Receives $1.5 Million for Alleging Cybersecurity Non-Compliance

Ruling Striking Down Trump Order Targeting Law Firm Seen as Crucial for Whistleblowers

MJH Healthcare Settles Whistleblower Allegations of Postal Rate Fraud for $2 Million

Poll Shows Overwhelming Support for Stronger Whistleblower Laws in Australia, Mirroring Polling in US

Four Whistleblowers Receive $1.3 Million for Alleging Genetic Testing Fraud Scheme

Whistleblower Poll

Whistleblower Poll
Whistleblower Poll

Exclusive Marist Poll: Overwhelming Public Support Among Likely Voters For Increased Whistleblower Protections

byGeoff Schweller
October 6, 2020

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

STAY INFORMED.
Subscribe to receive breaking whistleblower updates.

  • This field is for validation purposes and should be left unchanged.

About Us

  • About
  • Contact Us
  • Donate
  • Careers

Subscribe

  • Daily Mail
  • Follow us on Twitter
  • YouTube Channel

Contribute

  • Letter to the Editor
  • Submission Guidelines
  • Reprint Guidelines

Your Experience

  • Accessibility Statement
  • Privacy Policy
  • Terms of Use

Help

  • Rules for Whistleblowers
  • Frequently Asked Questions
  • Advertise
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments. 

Submit an Article

Copyright © 2025, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

Become a Whistleblower Network News Subscriber

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Subscribe to WNN

Retrieve your password

Please enter your username or email address to reset your password.

Subscribe to WNN
RSVP to National Whistleblower Day 2025! July 30, 2025 on Capitol Hill
RSVP NOW

Add New Playlist

No Result
View All Result
  • Exclusives
  • Government
    • False Claims-Qui Tam
    • Federal Employees
    • Intelligence
  • Corporate
    • CFTC & Commodities
    • Dodd-Frank
    • IRS & Tax
    • SEC & Securities
  • Features
  • Legislation
  • International
    • Foreign Corruption
  • Rewards
  • Whistleblower of the Week
  • Environment & Climate
  • Opinion
  • Editorial
  • Employment
    • Sarbanes-Oxley Whistleblowers
    • Retaliation
    • OSHA
  • Make National Whistleblower Day Permanent
  • Media
    • Podcasts
    • Videos
    • Webinars
    • National Whistleblower Day
  • Whistleblower Poll
  • Whistleblower Resources
    • Frequently Asked Questions
    • Resources for Locating An Attorney
    • The New Whistleblowers Handbook

Copyright © 2024, Whistleblower Network News. All Rights Reserved.

Go to mobile version